FDA Aims to Expand Early-Approval Program for Promising Drugs
- Commissioner proposes approval based on early, small trials
- Scott Gottlieb speaks before House subcommittee on health
Photographer: Tomohiro Ohsumi/Bloomberg
This article is for subscribers only.
The Food and Drug Administration wants to help patients get faster access to promising cancer treatments.
The agency is preparing proposals that would expand an accelerated-approval program for lifesaving medications, FDA Commissioner Scott Gottlieb told House lawmakers on Thursday.